Hycamtin topotecan hydrochloride: Phase III data

Data from a Phase III trial of oral Hycamtin in 784 chemotherapy-naïve patients with SCLC showed that overall survival, the primary endpoint, was similar between oral Hycamtin plus IV cisplatin and IV...